BLACK DIAMOND THERAPEUTICS
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small-molecule. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer. Black Diamond focused on the discovery and development of precision medicines for cancer that is directed against a novel class of allosteric mutant oncogenes. The company targets undrugged mutations in patients with genetically defined cancers for whom limited treatment options currently exist. It is built upon a deep understanding of cancer genetics, protein structure and function, and medicinal chemistry.
BLACK DIAMOND THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science Medical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.blackdiamondtherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
617-417-5868
Email Addresses:
[email protected]
Total Funding:
197.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Organization Schema Office 365 Mail IPv6
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Current Advisors List
Current Employees Featured
![]()
Founder
![]()
Stock Details
Investors List
Nextech Invest
Nextech Invest investment in Series C - Black Diamond Therapeutics
BVF Partners
BVF Partners investment in Series C - Black Diamond Therapeutics
Logos Capital
Logos Capital investment in Series C - Black Diamond Therapeutics
![]()
Perceptive Advisors
Perceptive Advisors investment in Series C - Black Diamond Therapeutics
![]()
Invus
Invus investment in Series C - Black Diamond Therapeutics
Wellington Management
Wellington Management investment in Series C - Black Diamond Therapeutics
![]()
Versant Ventures
Versant Ventures investment in Series C - Black Diamond Therapeutics
![]()
New Enterprise Associates
New Enterprise Associates investment in Series C - Black Diamond Therapeutics
![]()
Roche Venture Fund
Roche Venture Fund investment in Series C - Black Diamond Therapeutics
![]()
City Hill Ventures
City Hill Ventures investment in Series C - Black Diamond Therapeutics
Key Employee Changes
Official Site Inspections
http://www.blackdiamondtherapeutics.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K
- Host name: cloudhost-10606077.us-midwest-2.nxcli.net
- IP address: 199.189.225.244
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
